Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome.
Drewe
E
E
McDermott
E M
EM
Powell
R J
RJ
D000328:Adult; D000686:Amyloidosis / Q000150:complications / Q000175:diagnosis; D000068800:Etanercept; D010505:Familial Mediterranean Fever / Q000150:complications*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007279:Injections, Subcutaneous; D007674:Kidney Diseases / Q000150:complications / Q000175:diagnosis; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000209:etiology; D018124:Receptors, Tumor Necrosis Factor / Q000235:genetics* / Q000627:therapeutic use*; D000683:Serum Amyloid P-Component; D014409:Tumor Necrosis Factor-alpha
D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000683:Serum Amyloid P-Component; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept